Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Med Vasc ; 45(4): 198-209, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32571560

ABSTRACT

AIM OF THE STUDY AND PATIENTS: Direct oral anticoagulants (DOA) tend to replace antivitamins K (VKA). The incidence of major and minor hemorrhages is higher in women, a difference potentially linked to genital hemorrhages. The objective is to assess the practices and perception of general practitioners of the use of oral anticoagulant therapy in women of childbearing age. MATERIALS AND METHODS: Descriptive, observational, transversal and monocentric study. An 11-items questionnaire was sent to 900 randomized general practitioners, assessing the type of patient, the type of anticoagulant prescribed, the management of genital bleeding, and the assessment of the quality of life of anticoagulated patients. RESULTS: DOA were the most prescribed anticoagulants. Genital hemorrhage was the second leading cause of minor hemorrhage. Most doctors (60.6%) believed they were due to VKAs. 25% reported an alteration in the quality of life of patients following these genital hemorrhages and 47.5% addressed this subject in consultation. CONCLUSION: Our study suggests that, according to the general practitioners interviewed, genital hemorrhage is more frequent on VKA than on DOA in women of reproductive age, which is contradictory with the data in the literature. The probably taboo subject is rarely mentioned in consultation and is responsible for a deterioration in the quality of life in these young patients. No recommendation exists on the management of this type of genital hemorrhage in these women. An algorithm is proposed for their management.


Subject(s)
Anticoagulants/adverse effects , Attitude of Health Personnel , General Practitioners/psychology , Health Knowledge, Attitudes, Practice , Reproductive Health , Uterine Hemorrhage/chemically induced , Women's Health , Anticoagulants/administration & dosage , Female , Humans , Maternal Age , Quality of Life , Risk Assessment , Risk Factors , Uterine Hemorrhage/diagnosis , Uterine Hemorrhage/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...